²é¿´: 1047  |  »Ø¸´: 8
¡¾Óн±½»Á÷¡¿»ý¼«»Ø¸´±¾Ìû×Ó£¬²ÎÓë½»Á÷£¬¾ÍÓлú»á·ÖµÃ×÷Õß FrozenM00N µÄ 2 ¸ö½ð±Ò £¬»ØÌû¾ÍÁ¢¼´»ñµÃ 1 ¸ö½ð±Ò£¬Ã¿ÈËÓÐ 1 ´Î»ú»á

FrozenM00N

¾èÖú¹ó±ö (³õÈëÎÄ̳)


[½»Á÷] ÃÀ¹úÓÌËû´óѧ·Ö×ÓÓ°ÏñºÍÄÉÃײÄÁÏ·½ÏòÕÐÊÕÈ«¶î½±Ñ§½ð²©Ê¿¡¢²©Ê¿ºóÒÔ¼°·ÃÎÊѧÕß

ÃÀ¹úÓÌËû´óѧÊÇÃÀ¹úÓÌËûÖݵĸߵȽÌÓýÆì½¢ÐÍ´óѧ£¬Ò²ÊÇÒ»ËùÊÀ½ç¶¥¼âµÄ¹«Á¢Ñо¿ÐÍ´óѧ£¬ÎªÌظßÑо¿ÐÍ´óѧ£¨Top-tier Research university£©¡£2021U.S. NewsÃÀ¹ú×î¼Ñ¹«Á¢´óѧÅÅÃûµÚ40룬2022WRWUÊÀ½ç´óѧÅÅÃûµÚ63룬2022Èí¿ÆÊÀ½ç´óѧѧÊõÅÅÃûµÚ101-150£¬2022U.S. NewsÊÀ½ç´óѧÅÅÃûµÚ151λ¡£

²©ºóÈëÖ°¿ÉѡҩѧԺ¡£ÓÌËû´óѧҩѧԺÊDZ¾Ð£ÍõÅÆѧ¿Æ£¬È«ÃÀҩѧԺÅÅÃû#14루U.S. News£©¡£

Dr. Sixiang Shi LabÕÐÊÕ²©Ê¿Éú£¨È«¶î½±Ñ§½ð£©Ò»Ãû£¬²©Ê¿ºóÒ»Ãû£¬²¢»¶Ó­·ÃÎÊѧÕßÇ°À´Ò»Æð¹¤×÷¡£¿ÎÌâ×éÖ÷ÒªÑо¿·Ö×ÓÓ°Ïñ¡¢ÉúÎï²ÄÁÏ¡¢°ÐÏòÖÎÁÆ¡¢ÃâÒßÁÆ·¨µÈ·½Ïò¡£Dr. Shi¹²·¢±í40ÓàƪÎÄÕ£¨ÒýÓÃ>3900, HÒò×Ó30£©£¬°üÀ¨ ACS Nano, Advanced Drug Delivery Reviews, Angewandte Chemie, Biomaterials, JNM, Nature NanotechnologyµÈ±¾ÁìÓò¶¥¼¶ÆÚ¿¯¡£µ£ÈÎJournal of Nanobiotechnology£¨IF=9.429)¸±Ö÷±à£¬²¢»ñµÃ SNMMI Ones to Watch 2020µÈÖî¶àÈÙÓþ¡£

ÕÐÉúÒªÇó£º
1. ·Ö×ÓÓ°Ïñ¡¢ÉúÎï¡¢»¯Ñ§¡¢²ÄÁϵÈÏà¹Ø±³¾°µÄ˶ʿÑо¿Éú»òÕß±¾¿ÆËÄÄ꼶ѧÉú¡£
2. ѧϰ³É¼¨ÓÅÒ죬ÓÐ×êÑо«Éñ¡£ÓпÆÑо­ÀúºÍÂÛÎÄ·¢±íÕßÓÅÏÈ¡£
3. ÓÐÁ¼ºÃµÄÓ¢ÎÄ»ù´¡£¬´ïµ½Íи£80·Ö»òÕßÑÅ˼6.5·Ö¡£

Ñо¿¿ÎÌ⣺·Ö×ÓÓ°Ïñ¡¢ÄÉÃײÄÁÏ¡¢ÃâÒßÁÆ·¨¡£

ÓÐÒâÕßÇëÁªÏµsixiang.shi@utah.edu
ÍøÒ³£ºhttps://imagingnanolabs.com/

¾ßÌåÕÐÉúÐÅÏ¢ÈçÏ£º

The Molecular Imaging and Nanotechnology Innovation Laboratory (MINILabs) is seeking graduate students, postdoctoral fellows, and visiting scholars to lead research efforts at the intersection of molecular imaging and nanomedicine. Our core mission is to revolutionize the way we visualize, understand and treat cancer and other diseases, by potentiating simple but powerful solutions to biomedical and healthcare challenges.

Laboratory Research Directions:
1.        Application of advanced molecular imaging techniques (PET/CT, optics, optoacoustic imaging, etc.) in cancer, regenerative medicine and other diseases;
2.        Development of innovative nanomedicine and natural biomaterials (e.g. extracellular vesicles) for personalized theranostics;
3.        Development of novel radiochemistry and targeted radiotherapy for refractory diseases;
4.        Utilizing advanced imaging tools to understand the biological unknowns in tumor microenvironment, metastasis, immunology, etc.  

Trainees will be a part of a highly multidisciplinary and collaborative group within the Department of Radiology and Imaging Sciences and the Department of Molecular Pharmaceutics at the University of Utah, led jointly by PIs Dr. Shi and Dr. Goel. The excellent academic environment at the University of Utah offers excellent career development and enhancement opportunities at all levels.  

Applicant Requirements:
1.        Familiarity with advanced techniques in molecular biology, biomedical imaging and biomaterials research is preferred.
2.        Successful candidates will be motivated, curious and independent thinkers with a strong sense of responsibility and good oral and written communication skills.
3.        Applicants for PhD program should be final-year masters/4th-year undergraduate students or the students who recently graduated.
4.        The students exhibiting outstanding performance with excellent GPA and research track record will be given preference.
5.        The international students must successfully complete the English Proficiency Test (TOEFL 80 or IELTS 6.5).
6.        Applicants for postdoctoral fellows with outstanding publication record and ability to work independently will be given priority.

Contact: Interested candidates are recommended to send their CVs to Dr. Sixiang Shi (sixiang.shi@utah.edu).

Principal Investigator (PI): Dr. Sixiang Shi received his PhD degree in Materials Science and Engineering from the University of Wisconsin-Madison in 2016 and completed his postdoctoral fellowship from MD Anderson Cancer Center in 2020. He shortly worked in the Department of Health Technology and Informatics at the Hong Kong Polytechnic University as an Assistant Professor in 2021. He joined the Department of Radiology and Imaging Sciences at the University of Utah in August 2022. So far, he has published >40 papers (>3900 citations, h-index: 30), in top journals such as ACS Nano, Advanced Drug Delivery Reviews£¬ Angewandte Chemie, Biomaterials, JNM, Nature Nanotechnology, among others. Dr. Shi serves as Associate Editor for Journal of Nanobiotechnology, Editorial Member for Journal of Functional Biomaterials, and reviewer for more than 20 journals, scientific societies, grants agencies and conferences. Dr. Shi has received multiple awards and honors for his research and scholarship, including the SNMMI Ones to Watch 2020, which recognizes most promising researchers worldwide in the fields of nuclear medicine and molecular imaging. Details can be found via https://imagingnanolabs.com/.
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍƼö: (ÎÒÒ²ÒªÔÚÕâÀïÍƹã)

» ÇÀ½ð±ÒÀ²£¡»ØÌû¾Í¿ÉÒԵõ½:

²é¿´È«²¿É¢½ðÌù

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chenhuanlong

гæ (ÎÄѧ̩¶·)


¡ï
FrozenM00N(½ð±Ò+1): лл²ÎÓë
8Â¥2023-05-08 18:45:13
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
¼òµ¥»Ø¸´
nono20092Â¥
2023-05-04 13:04   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
¡¤
tzynew3Â¥
2023-05-04 13:13   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
k ·¢×ÔСľ³æAndroid¿Í»§¶Ë
shenrenren4Â¥
2023-05-04 18:18   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
kingluck5Â¥
2023-05-04 23:52   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
XG-WUST6Â¥
2023-05-05 21:10   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
up ·¢×ÔСľ³æIOS¿Í»§¶Ë
2023-05-05 21:43   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
gordon3999Â¥
2023-05-09 07:34   »Ø¸´  
FrozenM00N(½ð±Ò+1): лл²ÎÓë
·¢×ÔСľ³æAndroid¿Í»§¶Ë
Ïà¹Ø°æ¿éÌøת ÎÒÒª¶©ÔÄÂ¥Ö÷ FrozenM00N µÄÖ÷Ìâ¸üÐÂ
Ìáʾ: Èç¹ûÄúÔÚ30·ÖÖÓÄڻظ´¹ýÆäËûÉ¢½ðÌù£¬Ôò¿ÉÄÜÎÞ·¨ÁìÈ¡´ËÌù½ð±Ò
×î¾ßÈËÆøÈÈÌûÍƼö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[ÂÛÎÄͶ¸å] Éó¸åÈËÒ»ÊÕÒ»¾Ü£¬±à¼­¸øÁËÐÞ +5 njuyck 2024-04-30 6/300 2024-05-02 13:23 by kingzgh
[ÂÛÎÄͶ¸å] Éó¸åÈËÆÀÉóÍê³É״̬»¹ÊÇunder review 5+3 ZH0826 2024-04-30 9/450 2024-05-02 13:13 by ZH0826
[ÎÞ»ú/Îﻯ] ¹ýÑõ»¯ÇâÑõ»¯ 10(½ð±Ò+5) +3 15132328891 2024-04-29 5/250 2024-05-02 11:08 by °²ºÓÇű±¤Å
[»ù½ðÉêÇë] ÎÒÆÀÉóÂÛÎÄ»áÈ¥ÉêÇëÈË¿ÆÑÐÖ®ÓÑÉϲéÆäÂÛÎÄ +7 zju2000 2024-05-01 11/550 2024-05-02 10:37 by xli1984
[Óлú½»Á÷] DMFÔõô³ýË® +5 °®³ÔÏã²ËµÄС»Æ¹ 2024-05-01 10/500 2024-05-02 08:27 by kang1386
[»ù½ðÉêÇë] ½ñÄêÃæÉÏÔ¤¼ÆÓÖ´ò½´ÓÍÁË +13 speedxyl 2024-04-30 15/750 2024-05-02 06:37 by llhljsy
[˶²©¼ÒÔ°] ¿ÆÑкÃÄÑ°¡£¬ÏëÍËѧȥ´ò¹¤¡£ +28 byywnyl 2024-04-27 31/1550 2024-05-02 06:06 by Çà¹Å
[ÂÛÎÄͶ¸å] µÚһƪÂÛÎÄÖÕÓÚ½øÈ¥Éó¸å״̬ÁË +4 lizhengke06 2024-05-01 7/350 2024-05-01 17:16 by wjykycg
[»ù½ðÉêÇë] µÚ¶þ´ÎÉêÇëÇà»ù£¬×£×Ô¼ººÃÔË! ÖÐ! ÖÐ! ÖÐ! +13 °¢ºÀv5 2024-04-29 15/750 2024-05-01 14:44 by Howard28
[˶²©¼ÒÔ°] С˶äÉóû¹ý +14 xmc2007 2024-04-28 14/700 2024-05-01 12:40 by shadowout
[¿¼²©] 2024»¹ÓÐûÓв¹Â¼µÄ²©Ê¿ +4 crazy peng 2024-04-30 5/250 2024-05-01 12:12 by crazy peng
[»ù½ðÉêÇë] ¹ú¼ÒÉç¿Æ¡°ÉêÇëÈ˿ɸù¾Ýʵ¼ÊÑо¿ÐèÒª£¬ÎüÊÕ¾³ÍâÑо¿ÈËÔ±×÷Ϊ¿ÎÌâ×é³ÉÔ±¡±Ôõô½â¶Áѽ£¿ +3 youyousong 2024-04-27 5/250 2024-05-01 09:43 by holypower
[ÂÛÎÄͶ¸å] Ͷ¸åRSCÆìÏÂÔÓ־ͻȻ¼ä¿´²»µ½Í¶¸å״̬£¬ÀïÃæͶ¸åµÄÎÄÕÂÐÅÏ¢²»¼ûÁË£¬ÓÐÓöµ½¹ýµÄÂ𣿠50+4 dlying 2024-04-26 4/200 2024-05-01 03:53 by mandytsui
[˶²©¼ÒÔ°] ²©Ê¿ºóºÍ¿ÆÑÐÖúÀíºÃÄÑÕÒ°¡ +11 ÕÒ¹¤×÷°¡ 2024-04-28 11/550 2024-04-30 21:48 by lizhengke06
[»ù½ðÉêÇë] ¹ØÓÚ¹«²¼2024Äê¶È¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÏîÄ¿ÉêÇë³õÉó½á¹ûµÄͨ¸æ +9 hdzw9071 2024-04-30 12/600 2024-04-30 20:07 by wangzhenyft
[¿¼²©] ÉêÇë25Ä격ʿ£¬ÇóÍƼöѧУ¼°²©µ¼ +4 Ã÷¿ªÒ¹ºÏ20 2024-04-28 7/350 2024-04-30 14:23 by Ã÷¿ªÒ¹ºÏ20
[·ÖÎö] C18É«Æ×Öù¿ÉÒÔ·ÖÎöµ¥ÌÇ£¬¶þÌÇ£¬µÍ¾ÛÌÇ£¨3-7£©Âð +5 ±¸°²Íø¹« 2024-04-26 6/300 2024-04-30 09:25 by shuiliu
[ÂÛÎÄͶ¸å] optics expressͶ¸åÇóÖú +4 ´ø´ø´óÖÜ 2024-04-25 6/300 2024-04-29 16:52 by laozhao02
[ÂÛÎÄͶ¸å] Jounal of EthnopharmacologyͶ¸å +3 layľ×ÓºÌ 2024-04-25 4/200 2024-04-28 16:58 by hanyunch
[¿¼ÑÐ] ûѧÉÏ +7 ¼¾ÏòÑô 2024-04-26 13/650 2024-04-27 20:38 by Ò»ÌõÏÌÓã.
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û